These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23315964)

  • 1. C-reactive protein, a prognostic marker in hepatocellular carcinoma.
    Dufour JF
    Hepatology; 2013 Jun; 57(6):2103-5. PubMed ID: 23315964
    [No Abstract]   [Full Text] [Related]  

  • 2. Malondialdehyde and C-reactive protein as prognostic markers of hepatocellular carcinoma.
    Elbaz S; Mousa N; Besheer T; Sheta T; Taha K; Awad M; Effat N; Elgamal A; Abdel-Razik A
    Br J Biomed Sci; 2020 Apr; 77(2):94-96. PubMed ID: 31971480
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis: Novel prognostic biomarkers in hepatocellular carcinoma.
    Pang RW; Poon RT
    Nat Rev Gastroenterol Hepatol; 2012 Dec; 9(12):691-2. PubMed ID: 23147657
    [No Abstract]   [Full Text] [Related]  

  • 4. Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma.
    Sieghart W; Pinter M; Hucke F; Graziadei I; Schöniger-Hekele M; Müller C; Vogel W; Trauner M; Peck-Radosavljevic M
    Hepatology; 2013 Jun; 57(6):2224-34. PubMed ID: 22961713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nonspecific tumor markers in hepatocellular carcinoma].
    Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509
    [No Abstract]   [Full Text] [Related]  

  • 6. [Polymyositis and hepatocarcinoma: a case report from Gabon].
    Iba-Ba J; Assengone Zeh Y; Bignoumba Ibouili R; Missounga L; Lasseghe D; Coniquet S; Moussavou Kombila JB; Boguikouma JB
    Med Trop (Mars); 2009 Dec; 69(6):548. PubMed ID: 20099664
    [No Abstract]   [Full Text] [Related]  

  • 7. Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.
    Zou ZQ; Ding YP; Long B; Yuh JG; Xu AL; Lang ZW; Zou SY; Liu YD; Ding K; Li YY
    Hepatogastroenterology; 2010; 57(102-103):1285-90. PubMed ID: 21410073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of a new inflammation-based scoring system for prognostication of patients with hepatocellular carcinoma after hepatectomy.
    Mori S; Kita J; Kato M; Shimoda M; Kubota K
    Am J Surg; 2015 Jan; 209(1):187-93. PubMed ID: 24950991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
    Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
    Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatocellular carcinoma with lymphoid stroma: report of two cases].
    Choi HJ; Choi JH
    Korean J Hepatol; 2008 Sep; 14(3):394-8. PubMed ID: 18815463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PIVKA-II as a serological marker of hepatocellular carcinoma].
    Jeong SH
    Korean J Hepatol; 2006 Sep; 12(3):315-7. PubMed ID: 16998285
    [No Abstract]   [Full Text] [Related]  

  • 12. Marker panels for the diagnosis of small hepatocellular carcinoma, a never-ending story.
    Bioulac-Sage P; Balabaud C
    Clin Res Hepatol Gastroenterol; 2011 Sep; 35(8-9):513-5. PubMed ID: 21703963
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of alpha-fetoprotein as tumor marker for hepatocellular carcinoma (author's transl)].
    Tang ZY; Yang BH
    Zhonghua Zhong Liu Za Zhi; 1981 Aug; 3(3):205-9. PubMed ID: 6175491
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
    Shiraki K; Takase K; Tameda Y; Hamada M; Kosaka Y; Nakano T
    Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MR image of early hepatocellular carcinoma and hepatocellular carcinoma with early components].
    Muramatsu Y; Nawano S; Moriyama N; Takayasu K
    Nihon Rinsho; 1991 Aug; 49(8):1815-20. PubMed ID: 1664886
    [No Abstract]   [Full Text] [Related]  

  • 16. [Why no consensus prognostic classification for hepatocellular carcinoma?].
    Barbare JC; Bellenguez A; Diouf M
    Rev Prat; 2013 Feb; 63(2):218-9. PubMed ID: 23513789
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tumor markers for hepatocellular carcinoma].
    Tateishi R; Enooku K; Shiina S; Koike K
    Nihon Rinsho; 2012 May; 70(5):821-7. PubMed ID: 22620007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum B protein in hepatocellular carcinoma and liver cirrhosis.
    Chang WY; Lin ZY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1990 Nov; 6(11):599-605. PubMed ID: 2175815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative evaluation and postoperative complications with prognostic impact of surgical resection for the hepatocellular carcinoma in cirrhotics].
    Kang KJ
    Korean J Hepatol; 2006 Dec; 12(4):479-83. PubMed ID: 17237625
    [No Abstract]   [Full Text] [Related]  

  • 20. The Glasgow Prognostic Score is an independent prognostic predictor of hepatocellular carcinoma following radical resection.
    Pan QX; Zhang JH; Su ZJ; Wang CR; Ke SY
    Oncol Res Treat; 2014; 37(4):192-7. PubMed ID: 24732643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.